120 related articles for article (PubMed ID: 38043603)
1. Simvastatin induces degradation of the extracellular matrix in human leiomyomata: novel in vitro, in vivo, and patient level evidence of matrix metalloproteinase involvement.
Britten J; Roura-Monllor JA; Malik M; Moran S; DeAngelis A; Driggers P; Afrin S; Borahay M; Catherino WH
F S Sci; 2024 Feb; 5(1):80-91. PubMed ID: 38043603
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production.
Malik M; Britten J; Borahay M; Segars J; Catherino WH
Fertil Steril; 2018 Dec; 110(7):1398-1407.e1. PubMed ID: 30503138
[TBL] [Abstract][Full Text] [Related]
3. Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.
Cox J; Malik M; Britten J; Lewis T; Catherino WH
Reprod Sci; 2018 Feb; 25(2):198-206. PubMed ID: 28929861
[TBL] [Abstract][Full Text] [Related]
4. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
Joseph DS; Malik M; Nurudeen S; Catherino WH
Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation.
Afrin S; El Sabeh M; Islam MS; Miyashita-Ishiwata M; Malik M; Catherino WH; Akimzhanov AM; Boehning D; Yang Q; Al-Hendy A; Segars JH; Borahay MA
Pharmacol Res; 2021 Oct; 172():105856. PubMed ID: 34461224
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits human leiomyoma xenograft tumor growth and induces dissolution of the extracellular matrix.
Malik M; Britten JL; DeAngelis A; Sitler C; Moran S; Roura-Monllor JA; Driggers P; Catherino WH
F S Sci; 2023 Feb; 4(1):74-89. PubMed ID: 36273722
[TBL] [Abstract][Full Text] [Related]
7. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
Borahay MA; Vincent K; Motamedi M; Sbrana E; Kilic GS; Al-Hendy A; Boehning D
Am J Obstet Gynecol; 2015 Aug; 213(2):196.e1-8. PubMed ID: 25840272
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells.
Afrin S; Islam MS; Patzkowsky K; Malik M; Catherino WH; Segars JH; Borahay MA
Am J Obstet Gynecol; 2020 Nov; 223(5):733.e1-733.e14. PubMed ID: 32417359
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
10. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
11. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
12. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
Morikawa A; Ohara N; Xu Q; Nakabayashi K; DeManno DA; Chwalisz K; Yoshida S; Maruo T
Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
Carbajo-García MC; García-Alcázar Z; Corachán A; Monleón J; Trelis A; Faus A; Pellicer A; Ferrero H
Fertil Steril; 2022 Feb; 117(2):433-443. PubMed ID: 34809976
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-β3 and Wnt/β-Catenin pathways.
Afrin S; Ali M; El Sabeh M; Yang Q; Al-Hendy A; Borahay MA
J Cell Mol Med; 2022 Mar; 26(5):1684-1698. PubMed ID: 35118811
[TBL] [Abstract][Full Text] [Related]
15. Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
Levy G; Malik M; Britten J; Gilden M; Segars J; Catherino WH
Fertil Steril; 2014 Jul; 102(1):272-281.e2. PubMed ID: 24825427
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma.
El Sabeh M; Saha SK; Afrin S; Borahay MA
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34614511
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.
Lewis TD; Malik M; Britten J; San Pablo AM; Catherino WH
Biomed Res Int; 2018; 2018():2414609. PubMed ID: 29780819
[TBL] [Abstract][Full Text] [Related]
18. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
Patel A; Malik M; Britten J; Cox J; Catherino WH
Fertil Steril; 2016 Apr; 105(4):1102-10. PubMed ID: 26776909
[TBL] [Abstract][Full Text] [Related]
19. Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
Gilden M; Malik M; Britten J; Delgado T; Levy G; Catherino WH
Fertil Steril; 2012 Dec; 98(6):1557-62. PubMed ID: 22925684
[TBL] [Abstract][Full Text] [Related]
20. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
